"Girls" star and director Lena Dunham is sparking a national dialogue on women's health after revealing she had a hysterectomy. LiveScience's Sara Miller and SELF's Casey Gueren join Cheddar to reveal why the star elected to have the procedure. Dunham underwent surgery after battling with the painful condition, endometriosis. Miller and Gueren explain what endometriosis is, and why it's unusual for a woman so young to decide to have a hysterectomy. About one in ten women have endometriosis. We consider whether Dunham's story will educate more women about the disease and its symptoms. Dunham's essay is sparking a national dialogue about women's health issues. We also learn whether the star would still be able to have a child through surrogacy.

Share:
More In Culture
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
First-Time Homebuyers Face Rising Mortgage Rates
Buying a new home is tough right now; but for first-time buyers, it's an especially challenging time, with obstacles like rising mortgage rates and record-breaking home prices. The housing market is not expected to get much friendlier, as mortgage rates are expected to continue to climb as the Federal Reserve proceeds with its plans for rate hikes in an effort to stifle inflation. Jonathan Miller, President and CEO of real estate appraiser Miller Samuel, joins Cheddar News' Closing Bell to discuss.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Load More